Results

Total Results: 412 records

Showing results for "substance abuse".
Users also searched for: pressure injuries

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - Age group (< 6 years, 6–12 years, 13–18 years, 19–24 years); 3) Race; 4) Co-morbidities, including substanceabuse, ADHD; 5) Co-treatment versus monotherapy; 6) First episode psychosis vs. treatment in context
  2. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
    August 01, 2013 - Substance abuse 15. … Some of the priority areas (e.g., developmental delays, substance abuse, pulmonary) may have very few … Examples of subcategories: Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Emphysema 14 Substanceabuse Examples of subcategories: Alcohol, Cocaine, Opioids, Tobacco 15 Cross cutting Examples of
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
    April 22, 2013 - Peer Reviewer 6 General The definition of the target population also states "but not substance abuse … Almost half of persons with SMI have a secondary dx of substance use disorder at some time in the course … We modified this definition to clarify that SMI does not include individuals who only have a substanceabuse disorder.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
    June 29, 2019 - Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults: Protocol Evidence-based Practice Center Technical Brief Protocol Project Title: Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults I. Background an…
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary Comparative Effectiveness Review Number 193 Effective Health Care Program Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel Executive Summary Background…
  6. effectivehealthcare.ahrq.gov/sites/default/files/cer-224-depression-children-comments.pdf
    April 10, 2020 - “Depression Chronicity: In a sample with comorbid depression and substance use disorder, those with … Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substanceuse disorders.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
    April 10, 2020 - “Depression Chronicity: In a sample with comorbid depression and substance use disorder, those with … Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substanceuse disorders.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plant-based-chronic-pain-review-q3.pdf
    September 01, 2021 - (e.g., age, race, ethnicity, sex, socioeconomic status) • Comorbidities, including past or current substanceuse disorders, mental health disorders, medical comorbidities, and high risk for opioid use disorder
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-treatments-for-acute-pain.pdf
    January 01, 2022 - Substance Abuse Detection/ 30. Drug Monitoring/ 31. … Substance Abuse Detection/ 30. Drug Monitoring/ 31. … *Special populations:  General adult  Older populations >65 years  Patients with history of substanceuse disorder  Patients currently under treatment for opioid use disorder with opioid agonist
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
    May 01, 2022 - Substance Abuse Detection/ 30. Drug Monitoring/ 31. … Substance Abuse Detection/ 30. Drug Monitoring/ 31. … *Special populations:  General adult  Older populations >65 years  Patients with history of substanceuse disorder  Patients currently under treatment for opioid use disorder with opioid agonist
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
    January 01, 2024 - White Paper_Living Systematic Reviews: Examining Excluded Full-Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chronic Pain White Paper Living Systematic Reviews: Examining Excluded Full- Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chroni…
  12. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/main-apps-surv-rept-1-acute-pain.pdf
    February 01, 2022 - Substance Abuse Detection/ 30. Drug Monitoring/ 31. … Substance Abuse Detection/ 30. Drug Monitoring/ 31. … *Special populations:  General adult  Older populations >65 years  Patients with history of substanceuse disorder  Patients currently under treatment for opioid use disorder with opioid agonist
  13. effectivehealthcare.ahrq.gov/health-topics/underage-drinking
  14. effectivehealthcare.ahrq.gov/health-topics/birth-weight/
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
    May 01, 2022 - (e.g., age, race, ethnicity, sex, socioeconomic status) • Comorbidities, including past or current substanceuse disorders, mental health disorders, medical comorbidities, and high risk for opioid use disorder
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - (e.g., age, race, ethnicity, sex, socioeconomic status) • Comorbidities, including past or current substanceuse disorders, mental health disorders, medical comorbidities, and high risk for opioid use disorder
  17. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
    May 01, 2022 - (e.g., age, race, ethnicity, sex, socioeconomic status) • Comorbidities, including past or current substanceuse disorders, mental health disorders, medical comorbidities, and high risk for opioid use disorder
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
    June 01, 2011 - );13 metabolic, nutritional, and endocrine conditions (one report);14 mental health conditions and substanceabuse (one report);15 heart and vascular diseases (one report);16 and kidney/urological conditions … abuse Integration of mental health/substance abuse and primary care 2008 15 11 University of Ottawa … Integration of mental health/substance abuse and primary care. … abuse and primary care We used the discovery process that is inherent in the review process.
  19. effectivehealthcare.ahrq.gov/products/migraine-treatments/protocol
    January 08, 2020 - other characteristics (e.g. older population, pregnant/breastfeeding women, patients with history of drugabuse/misuse/overdose). … *Special populations: General adult Older populations >65 years Patients with history of substanceuse disorder Patients currently under treatment for opioid use disorder with opioid agonist therapy
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
    January 09, 2020 - other characteristics (e.g. older population, pregnant/breastfeeding women, patients with history of drugabuse/misuse/overdose). … *Special populations: o General adult o Older populations >65 years o Patients with history of substanceuse disorder o Patients currently under treatment for opioid use disorder with opioid agonist therapy

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: